about
Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringThe use of dynamic nuclear polarization (13)C-pyruvate MRS in cancerSerine, glycine and one-carbon units: cancer metabolism in full circleMetabolic Imaging in Prostate Cancer: Where We AreThree-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancerEvaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.PET/CT in Oncology: Current Status and Perspectives.Radiosyntheses using fluorine-18: the art and science of late stage fluorinationRadiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETDual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancerPositron emission tomography for benign and malignant disease.Metabolic positron emission tomography imaging in cancer detection and therapy response.Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.Positron emission tomography in uro-oncology.Development of radiotracers for oncology--the interface with pharmacologyLymphatic imaging: focus on imaging probes.The next generation of positron emission tomography radiopharmaceuticals in oncology.Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse.PET/CT Imaging and Radioimmunotherapy of Prostate CancerFunctional imaging for prostate cancer: therapeutic implications.Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.Imaging localized prostate cancer: current approaches and new developments.Targeted molecular imaging in oncology: focus on radiation therapy.Choline Molecular Imaging with Small-animal PET for Monitoring Tumor Cellular Response to Photodynamic Therapy of Cancer.Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.Quality assurance of positron emission tomography/computed tomography for radiation therapy.Registration methodology for histological sections and in vivo imaging of human prostatePharmacodynamic markers for choline kinase down-regulation in breast cancer cells.New horizons in prostate cancer imaging.Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).Molecular imaging of urogenital diseases.Imaging metastatic bone disease from carcinoma of the prostateQuantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring.Metabolomics: a novel approach to early and noninvasive prostate cancer detection.Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.Imaging with non-FDG PET tracers: outlook for current clinical applications.
P2860
Q26765882-FBE51A6B-80D9-45E2-8423-F382D0ADA2D6Q26778444-AAD52AD4-166A-4327-8D44-FF58CBA53146Q26828610-0FF65AEF-821D-4A73-B79B-4ADA0145E3F2Q28074429-B1893A78-52F2-4A5E-8EA3-D3DFAA02BF79Q30606336-AC9734BC-6914-4032-8D2D-28D1C8A33378Q30755589-06F1E321-5FB2-49C0-9618-664802F34973Q33665109-EEC5B71E-2ABA-452F-B614-9C55E2DC97C0Q34074437-74BC6EF3-81A3-4450-B9D3-A21E6B760D8AQ34235986-D9B178E7-B989-4C29-AE76-82D05015BDEEQ34465066-C56775CA-E416-48BF-8CDB-F58492A05E3AQ34494815-798399AF-8C60-45AE-924B-9E6225460841Q34786518-8141740B-8395-4C35-AFBA-3370EEAB7B32Q35058000-8E07C5D1-1D8B-4F0E-91FD-AFBCB3628B4BQ35108246-343F27A7-095A-40BF-86B5-A5C2EB78830FQ35155500-BDBE3579-8256-4BB9-A633-49622F599FD4Q35172954-48E431CC-2B0B-403F-89F6-D60A5769934DQ35195500-BE46F8B1-9888-4270-8AAE-ECA9941835D7Q35475925-E46C78A9-B738-407D-94AA-68CEBC196145Q35525690-40A62BE3-CCDF-4BDA-9BD3-8E9AFD8C06C8Q35604502-897F4F22-45A4-46B2-A546-0FCCAD454360Q35849174-9DB8C492-606E-4E36-B02E-C64E1FABBDC6Q36085426-A10CEEA1-E81F-4D60-ADC6-0FD921D176A5Q36128629-012B5F8A-893E-463F-9572-A6BF1BA38424Q36450040-E1AC3E19-2BC9-47C6-B3EE-0FEAD60EA83AQ36469177-5E76C3BA-3793-4886-93AD-2E019F95F7E3Q36528175-C01242C6-4210-46FC-8D41-117D1A3D9B1DQ36537257-2608AE9C-4A83-4FB0-B057-6C186EA37223Q36604092-52A2D889-6106-4B2A-8314-CB3680A6DA4DQ36624124-F3A98719-C8B9-4BC3-8B12-FC224E3DAC35Q37011261-FA02BF77-8A46-4F10-B613-2F336B1500E9Q37105128-DF679D0D-FB08-485B-A1E7-2FE98A24EE6EQ37165855-91E5BC68-BB0D-4ADC-A32D-A8486E6434ADQ37242030-91A6A65A-FC4A-4486-8942-E916B61840D9Q37301288-9A8F5D67-F0C0-468C-9284-974589225CE6Q37550399-E3C6FEE7-4BC2-42F9-B3B3-5F2F5CA68114Q37605543-01FEC5C2-0818-4DD8-BA15-168223CC0FAEQ37714485-237AA176-5B4E-4F96-AE48-CCD49940DA2BQ37850315-88337D72-4037-4ABB-80FD-D8FB94C50312Q37973351-C1979DC4-0707-4919-9A85-ED2AE36EE0B8Q37986065-1480C152-8DE3-4DDD-811E-B9C34F739BD8
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
PET imaging of prostate cancer using carbon-11-choline.
@ast
PET imaging of prostate cancer using carbon-11-choline.
@en
PET imaging of prostate cancer using carbon-11-choline.
@nl
type
label
PET imaging of prostate cancer using carbon-11-choline.
@ast
PET imaging of prostate cancer using carbon-11-choline.
@en
PET imaging of prostate cancer using carbon-11-choline.
@nl
prefLabel
PET imaging of prostate cancer using carbon-11-choline.
@ast
PET imaging of prostate cancer using carbon-11-choline.
@en
PET imaging of prostate cancer using carbon-11-choline.
@nl
P2093
P1476
PET imaging of prostate cancer using carbon-11-choline
@en
P2093
P304
P407
P577
1998-06-01T00:00:00Z